India's Indoco Remedies rises on FDA approval for anti-smoking drug
** Shares of Indoco Remedies INRM.NS rise as much as 5% to
317.50 rupees
** Co gets U.S. FDA approval for varenicline tablets, which
are used to help quit smoking
** INRM last up about 2%, set to snap nine-session losing
streak
** Stock still down ~22% so far this year, on track for
third straight year of losses
** YTD, peers Pfizer Ltd PFIZ.NS and Ajanta Pharma
AJPH.NS up ~20% and ~43%, respectively
(Reporting by Dimpal Gulwani in Bengaluru)
((dimpal.gulwani@thomsonreuters.com))
Recent news on Ajanta Pharma
See all newsIndia's Ajanta Pharma falls as analysts say growth to moderate in H2
Brief: Ajanta Pharma Limited Sept-Quarter Consol Net Profit 3.88 Billion Rupees
India's Ajanta Pharma jumps on June quarter profit jump
Brief: Ajanta Pharma June-Quarter Consol PAT 3.34 Billion Rupees
Brief: Ajanta Pharma Receives US FDA Establishment Inspection Report For Paithan Facility